ACADIA PHARMACEUTICALS INC — SC 13G/A Filings
95 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by ACADIA PHARMACEUTICALS INC (ACAD), sorted by most recent first. Each row links to the full filing on EdgarLookup. ACADIA PHARMACEUTICALS INC has filed 95 SC 13G/A documents with the SEC since 2010. To view all SEC filings by ACADIA PHARMACEUTICALS INC, see the full filings list.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
POS AM
PRE 14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | ACADIA PHARMACEUTICALS INC | 0000902664-24-006501 | Nov 14, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020162 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000315066-24-000977 | Feb 9, 2024 | — |
| SC 13G/A | — | 0001086364-24-004855 | Jan 26, 2024 | — |
| SC 13G/A | — | 0000080255-23-002572 | Feb 14, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015189 | Feb 9, 2023 | — |
| SC 13G/A | — | 0000315066-23-001363 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001306550-23-005947 | Feb 1, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-22-016358 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000315066-22-000820 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000080255-21-001129 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-017327 | Feb 10, 2021 | — |
| SC 13G/A | — | 0000315066-21-000808 | Feb 8, 2021 | — |
| SC 13G/A | — | 0000834237-20-009942 | Jul 10, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-20-018610 | Feb 12, 2020 | — |
| SC 13G/A | — | 0000315066-20-000814 | Feb 7, 2020 | — |
| SC 13G/A | — | 0000834237-20-004587 | Feb 5, 2020 | — |
| SC 13G/A | SCHEDULE 13G/A, #1 | 0000899140-19-000214 | Feb 14, 2019 | — |
| SC 13G/A | — | 0000315066-19-000817 | Feb 13, 2019 | — |
| SC 13G/A | JANUS HENDERSON GROUP PLC OWNS <5% NOW | 0001274173-19-000006 | Feb 11, 2019 | — |
| SC 13G/A | — | 0000932471-19-004238 | Feb 11, 2019 | — |
| SC 13G/A | — | 0000215457-19-003088 | Feb 4, 2019 | — |
| SC 13G/A | — | 0000315066-18-001029 | Feb 13, 2018 | — |
| SC 13G/A | — | 0000932471-18-003099 | Feb 8, 2018 | — |
| SC 13G/A | — | 0000315066-17-001389 | Feb 14, 2017 | — |
| SC 13G/A | — | 0000932471-17-000598 | Feb 9, 2017 | — |
| SC 13G/A | — | 0000080255-17-000827 | Feb 6, 2017 | — |
| SC 13G/A | — | 0000215457-16-006408 | Jul 8, 2016 | — |
| SC 13G/A | SC 13G/A | 0001144204-16-082695 | Feb 16, 2016 | — |
| SC 13G/A | — | 0000315066-16-004819 | Feb 12, 2016 | — |
| SC 13G/A | ACAD AS OF 12/31/2015 | 0000080255-16-001075 | Feb 11, 2016 | — |
| SC 13G/A | — | 0000215457-16-001964 | Jan 25, 2016 | — |
| SC 13G/A | SC 13G/A | 0001144204-15-021168 | Apr 3, 2015 | — |
| SC 13G/A | — | 0001103804-15-000019 | Feb 17, 2015 | — |
| SC 13G/A | SC 13G/A | 0001144204-15-010189 | Feb 17, 2015 | — |
| SC 13G/A | — | 0000315066-15-001685 | Feb 13, 2015 | — |
| SC 13G/A | — | 0001086364-15-001442 | Feb 2, 2015 | — |
| SC 13G/A | SC 13G/A | 0001144204-14-009467 | Feb 14, 2014 | — |
| SC 13G/A | — | 0000315066-14-001848 | Feb 14, 2014 | — |
| SC 13G/A | SC 13G/A | 0001193125-14-054411 | Feb 14, 2014 | — |
| SC 13G/A | SCHEDULE 13G (AMENDMENT NO. 1) | 0001193125-13-060134 | Feb 14, 2013 | — |
| SC 13G/A | SC 13G/A | 0001144204-13-008958 | Feb 14, 2013 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001193125-13-060212 | Feb 14, 2013 | — |
| SC 13G/A | ACADIA PHARMACEUTICALS | 0001072613-13-000129 | Feb 13, 2013 | — |
| SC 13G/A | — | 0000315066-13-000045 | Jan 10, 2013 | — |
| SC 13G/A | SC 13G/A | 0001144204-12-067225 | Dec 10, 2012 | — |
| SC 13G/A | — | 0000315066-12-002308 | Feb 14, 2012 | — |
| SC 13G/A | SC 13GA | 0001144204-12-009028 | Feb 14, 2012 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001144204-12-008785 | Feb 14, 2012 | — |
| SC 13G/A | DISCLOSURE DOCUMENT | 0000902219-11-001054 | Nov 10, 2011 | — |